Robin Weiss

Photo: Courtesy of Robin Weiss Robin Weiss characterizes himself as a "one-track scientist." He researches "retroviruses, retroviruses, retroviruses." His colleagues, however, say he's a scientist's scientist who combines his prodigious knowledge with a propensity to ask questions others might not for fear of rocking the boat. Take, for example, the day in March 2001 when Weiss gave the Leeuwenhoek lecture at the London School of Tropical Medicine. According to Robert May, president of The Ro

Written byArlene Judith Klotzko
| 3 min read

Register for free to listen to this article
Listen with Speechify
0:00
3:00
Share

Robin Weiss characterizes himself as a "one-track scientist." He researches "retroviruses, retroviruses, retroviruses." His colleagues, however, say he's a scientist's scientist who combines his prodigious knowledge with a propensity to ask questions others might not for fear of rocking the boat.

Take, for example, the day in March 2001 when Weiss gave the Leeuwenhoek lecture at the London School of Tropical Medicine. According to Robert May, president of The Royal Society, who introduced him, "He began by asking those in the audience who held an organ donor card to raise their hand, and then admonishing those who did not. He followed this by putting on a containment suit and lecturing in it."

Currently professor of viral oncology at University College London, Weiss is "much more than one of the world's leading researchers in the general field of virology," May says. "He is also one of the most thoughtful--a rather different ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to digital editions of The Scientist, as well as TS Digest, feature stories, more than 35 years of archives, and much more!
Already a member? Login Here

Meet the Author

Published In

Share
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter Logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies